Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.14
Delayed Data
As of Jul 27
 +0.26 / +2.63%
Today’s Change
5.53
Today|||52-Week Range
13.84
-10.27%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 15.00. The median estimate represents a +57.79% increase from the last price of 10.14.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Merrimack Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$17.6M
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.00%
 
 
 
 
 
 
Growthannually -40.63%
 
 
 
 
 
 

Sales

Growthquarterly 18.39%
 
 
 
 
 
 
Growthannually -27.03%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account